Skip to Main Content

OBESITY

Semaglutide, a GLP-1 receptor agonist, is FDA-approved for the treatment of obesity.

Wilding JPH et al. N Engl J Med. [PMID: 33567185]

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.